Holy Stone Healthcare Co., Ltd.
Holy Stone Healthcare Co., Ltd. develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulce… Read more
Holy Stone Healthcare Co., Ltd. (4194) - Total Assets
Latest total assets as of December 2025: NT$220.52 Million TWD
Based on the latest financial reports, Holy Stone Healthcare Co., Ltd. (4194) holds total assets worth NT$220.52 Million TWD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Holy Stone Healthcare Co., Ltd. - Total Assets Trend (2019–2025)
This chart illustrates how Holy Stone Healthcare Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Holy Stone Healthcare Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2025)
Holy Stone Healthcare Co., Ltd.'s total assets of NT$220.52 Million consist of 74.8% current assets and 25.2% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 65.4% |
| Accounts Receivable | NT$0.00 | 0.0% |
| Inventory | NT$0.00 | 0.0% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Holy Stone Healthcare Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Holy Stone Healthcare Co., Ltd.'s current assets represent 74.8% of total assets in 2025, a decrease from 82.6% in 2019.
- Cash Position: Cash and equivalents constituted 65.4% of total assets in 2025, down from 69.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Holy Stone Healthcare Co., Ltd. Competitors by Total Assets
Key competitors of Holy Stone Healthcare Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Holy Stone Healthcare Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Holy Stone Healthcare Co., Ltd. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Holy Stone Healthcare Co., Ltd. is currently not profitable relative to its asset base.
Holy Stone Healthcare Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.29 | 5.98 | 8.61 |
| Quick Ratio | 5.29 | 5.98 | 8.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$133.76 Million | NT$ 245.50 Million | NT$ 375.92 Million |
Holy Stone Healthcare Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Holy Stone Healthcare Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.72 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -37.5% |
| Total Assets | NT$220.52 Million |
| Market Capitalization | $11.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values Holy Stone Healthcare Co., Ltd.'s assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Holy Stone Healthcare Co., Ltd.'s assets decreased by 37.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Holy Stone Healthcare Co., Ltd. (2019–2025)
The table below shows the annual total assets of Holy Stone Healthcare Co., Ltd. from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$220.52 Million | -37.53% |
| 2024-12-31 | NT$352.99 Million | +75.97% |
| 2023-12-31 | NT$200.59 Million | -67.37% |
| 2022-12-31 | NT$614.66 Million | +79.38% |
| 2021-12-31 | NT$342.66 Million | -34.45% |
| 2020-12-31 | NT$522.78 Million | -20.28% |
| 2019-12-31 | NT$655.74 Million | -- |